Literature DB >> 22441385

Microbiological challenges in the diagnosis of chronic Q fever.

Linda M Kampschreur1, Jan Jelrik Oosterheert, Annemarie M C Koop, Marjolijn C A Wegdam-Blans, Corine E Delsing, Chantal P Bleeker-Rovers, Monique G L De Jager-Leclercq, Cornelis A R Groot, Tom Sprong, Marrigje H Nabuurs-Franssen, Nicole H M Renders, Marjo E van Kasteren, Yvonne Soethoudt, Sybrandus N Blank, Marjolijn J H Pronk, Rolf H H Groenwold, Andy I M Hoepelman, Peter C Wever.   

Abstract

Diagnosis of chronic Q fever is difficult. PCR and culture lack sensitivity; hence, diagnosis relies mainly on serologic tests using an immunofluorescence assay (IFA). Optimal phase I IgG cutoff titers are debated but are estimated to be between 1:800 and 1:1,600. In patients with proven, probable, or possible chronic Q fever, we studied phase I IgG antibody titers at the time of positive blood PCR, at diagnosis, and at peak levels during chronic Q fever. We evaluated 200 patients, of whom 93 (46.5%) had proven, 51 (25.5%) had probable, and 56 (28.0%) had possible chronic Q fever. Sixty-five percent of proven cases had positive Coxiella burnetii PCR results for blood, which was associated with high phase I IgG. Median phase I IgG titers at diagnosis and peak titers in patients with proven chronic Q fever were significantly higher than those for patients with probable and possible chronic Q fever. The positive predictive values for proven chronic Q fever, compared to possible chronic Q fever, at titers 1:1,024, 1:2,048, 1:4,096, and ≥1:8,192 were 62.2%, 66.7%, 76.5%, and ≥86.2%, respectively. However, sensitivity dropped to <60% when cutoff titers of ≥1:8,192 were used. Although our study demonstrated a strong association between high phase I IgG titers and proven chronic Q fever, increasing the current diagnostic phase I IgG cutoff to >1:1,024 is not recommended due to increased false-negative findings (sensitivity < 60%) and the high morbidity and mortality of untreated chronic Q fever. Our study emphasizes that serologic results are not diagnostic on their own but should always be interpreted in combination with clinical parameters.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22441385      PMCID: PMC3346333          DOI: 10.1128/CVI.05724-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  22 in total

Review 1.  Natural history and pathophysiology of Q fever.

Authors:  D Raoult; Tj Marrie; Jl Mege
Journal:  Lancet Infect Dis       Date:  2005-04       Impact factor: 25.071

2.  Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak.

Authors:  Hervé Tissot-Dupont; Véronique Vaillant; Sylvie Rey; Didier Raoult
Journal:  Clin Infect Dis       Date:  2006-12-06       Impact factor: 9.079

3.  Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever.

Authors:  Peter M Schneeberger; Mirjam H A Hermans; Erik J van Hannen; Jeroen J A Schellekens; Alexander C A P Leenders; Peter C Wever
Journal:  Clin Vaccine Immunol       Date:  2009-12-23

4.  Q fever in the Netherlands: an update on the epidemiology and control measures.

Authors:  W van der Hoek; F Dijkstra; B Schimmer; P M Schneeberger; P Vellema; C Wijkmans; R ter Schegget; V Hackert; Y van Duynhoven
Journal:  Euro Surveill       Date:  2010-03-25

5.  Molecular detection of Coxiella burnetii in the sera of patients with Q fever endocarditis or vascular infection.

Authors:  F Fenollar; P E Fournier; D Raoult
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

6.  Long-term outcome of Q fever endocarditis: a 26-year personal survey.

Authors:  Matthieu Million; Franck Thuny; Hervé Richet; Didier Raoult
Journal:  Lancet Infect Dis       Date:  2010-07-14       Impact factor: 25.071

7.  Coxiella burnetii blood cultures from acute and chronic Q-fever patients.

Authors:  D Musso; D Raoult
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

8.  From acute Q fever to endocarditis: serological follow-up strategy.

Authors:  Cécile Landais; Florence Fenollar; Franck Thuny; Didier Raoult
Journal:  Clin Infect Dis       Date:  2007-04-04       Impact factor: 9.079

9.  Coxiella burnetii infection of aortic aneurysms or vascular grafts: report of 30 new cases and evaluation of outcome.

Authors:  E Botelho-Nevers; P-E Fournier; H Richet; F Fenollar; H Lepidi; C Foucault; A Branchereau; P Piquet; M Maurin; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-09       Impact factor: 3.267

10.  Q fever serology: cutoff determination for microimmunofluorescence.

Authors:  H T Dupont; X Thirion; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  1994-03
View more
  9 in total

1.  First isolation of Coxiella burnetii from clinical material by cell-free medium (ACCM2).

Authors:  K Boden; K Wolf; B Hermann; D Frangoulidis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-27       Impact factor: 3.267

2.  Coxiella burnetii - Pathogenic Agent of Q (Query) Fever.

Authors:  Lutz Gürtler; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-12-23       Impact factor: 3.747

3.  Serological follow-up in patients with aorto-iliac disease and evidence of Q fever infection.

Authors:  J C J P Hagenaars; N H M Renders; A S van Petersen; S O A Shamelian; M G L de Jager-Leclercq; F L Moll; P C Wever; O H J Koning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-12       Impact factor: 3.267

4.  Serology in chronic Q fever is still surrounded by question marks.

Authors:  M C A Wegdam-Blans; H T Tjhie; J M Korbeeck; M N Nabuurs-Franssen; L M Kampschreur; T Sprong; J A W Teijink; M P Koopmans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-16       Impact factor: 3.267

5.  Chronic Q fever in the Netherlands 5 years after the start of the Q fever epidemic: results from the Dutch chronic Q fever database.

Authors:  Linda M Kampschreur; Corine E Delsing; Rolf H H Groenwold; Marjolijn C A Wegdam-Blans; Chantal P Bleeker-Rovers; Monique G L de Jager-Leclercq; Andy I M Hoepelman; Marjo E van Kasteren; Jacqueline Buijs; Nicole H M Renders; Marrigje H Nabuurs-Franssen; Jan Jelrik Oosterheert; Peter C Wever
Journal:  J Clin Microbiol       Date:  2014-03-05       Impact factor: 5.948

6.  Chronic Q fever diagnosis— consensus guideline versus expert opinion

Authors:  Linda M Kampschreur; Marjolijn C A Wegdam-Blans; Peter C Wever; Nicole H M Renders; Corine E Delsing; Tom Sprong; Marjo E E van Kasteren; Henk Bijlmer; Daan Notermans; Jan Jelrik Oosterheert; Frans S Stals; Marrigje H Nabuurs-Franssen; Chantal P Bleeker-Rovers
Journal:  Emerg Infect Dis       Date:  2015-07       Impact factor: 6.883

7.  CXCL9, a promising biomarker in the diagnosis of chronic Q fever.

Authors:  Anne F M Jansen; Teske Schoffelen; Julien Textoris; Jean-Louis Mege; Marrigje Nabuurs-Franssen; Ruud P H Raijmakers; Mihai G Netea; Leo A B Joosten; Chantal P Bleeker-Rovers; Marcel van Deuren
Journal:  BMC Infect Dis       Date:  2017-08-09       Impact factor: 3.090

8.  Linking longitudinal and cross-sectional biomarker data to understand host-pathogen dynamics: Leptospira in California sea lions (Zalophus californianus) as a case study.

Authors:  K C Prager; Michael G Buhnerkempe; Denise J Greig; Anthony J Orr; Eric D Jensen; Forrest Gomez; Renee L Galloway; Qingzhong Wu; Frances M D Gulland; James O Lloyd-Smith
Journal:  PLoS Negl Trop Dis       Date:  2020-06-29

9.  Chronic Q Fever in Alberta: A Case of Coxiella burnetii Mycotic Aneurysm and Concomitant Vertebral Osteomyelitis.

Authors:  William Stokes; Jack Janvier; Stephen Vaughan
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-05-11       Impact factor: 2.471

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.